Huisa, Branko et al "Memantine and Cholinesterase Inhibitor Use in Alzheimer Disease Trials: Potential for Confounding by Indication (P6.178)." Neurology 90.15 Supplement (2018): P6.178. Web. 19 Aug. 2022.